SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-156247
Filing Date
2021-05-10
Accepted
2021-05-10 16:14:32
Documents
6
Period of Report
2021-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d420713d8k.htm 8-K 25658
2 EX-10.1 d420713dex101.htm EX-10.1 52556
3 EX-99.1 d420713dex991.htm EX-99.1 140162
4 EX-99.2 d420713dex992.htm EX-99.2 8942
5 GRAPHIC g420713g0507224634802.jpg GRAPHIC 4765
6 GRAPHIC g420713g0507231555508.jpg GRAPHIC 3829
  Complete submission text file 0001193125-21-156247.txt   240903
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 21907370
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences